| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| InMed Pharmaceuticals Inc. | Director | Employee Stock Option (Right to Buy) | 29,091 | 29 Dec 2021 | Direct | ||
| MERIDIAN BIOSCIENCE INC | Director | Common Stock | 0 | $20.38 | 31 Jan 2023 | Direct | |
| MERIDIAN BIOSCIENCE INC | Director | Stock Option (Right to Buy) | 0 | $13.25 | 31 Jan 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| VIVO | MERIDIAN BIOSCIENCE INC | 31 Jan 2023 | 9 | -$1,435,081 | 4 | Director | 31 Jan 2023, 13:21 |
| VIVO | MERIDIAN BIOSCIENCE INC | 26 Jan 2022 | 2 | $0 | 4 | Director | 28 Jan 2022, 10:43 |
| INM | InMed Pharmaceuticals Inc. | 29 Dec 2021 | 1 | $0 | 4 | Director | 30 Dec 2021, 17:03 |